 |
|
|
|
| Guidelines |
 APIC/CDC. Bioterrorism readiness plan: a template for healthcare facilities. [Full text]
Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002;8(2):222-5 [Full text]
CDC. Interim recommendations for firefighters and other first responders for the selection and use of protective clothing and respirators against biological agents [Full text]
CDC. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR 2001;50(43);941-8 [Full text]
CDC. Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001;50(42)909-19 [Full text]
CDC. Occupational health guidelines for remediation workers at Bacillus anthracis?contaminated sites?United States, 2001-2002. MMWR 2002 Sep 6;51(35):786-9 [Full text]
CDC. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR 2002 Nov 15;51(45):1024-6 [Full text]
FDA. FDA issues final rule and final order regarding safety and efficacy of certain licensed biological products including anthrax vaccine. Dec 30, 2003 [Full text]
Inglesby TV, O'Toole T, Henderson DA, et al, for the Working Group on Civilian Biodefense. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287(17) [Full text]
Turnbull PCB. Guidelines for the surveillance and control of anthrax in humans and animals. 3rd ed. World Health Organization, Department of Communicable Disease Surveillance and Response, 1998. [Full text]
|
